Skip to main content
. Author manuscript; available in PMC: 2011 Nov 10.
Published in final edited form as: Vaccine. 2010 Sep 25;28(48):7652–7658. doi: 10.1016/j.vaccine.2010.09.041

Table 3.

Post-dose 5 immune responses in subjects who received MV or placebo according to whether they developed definite TB during prospective follow up.

MV Placebo
Definite TB No definite TB Definite TB No definite TB
N Mean N Mean P value N Mean N Mean P value
IFN-γ response, pg/ml 14 191 498 545 0.3533 28 202.5 484 435.1 0.0080
Proliferative index 13 3.8 406 2.7 0.3557 27 2.7 392 1.9 0.9515
Antibody response to LAM, OD 28 0.53 797 0.61 0.5736 42 0.51 773 0.47 0.7482

P values by Mann-Whitney U test

IFN-γ response, interferon gamma response to MV soniciate; LAM, lipoarabinomannan; MV, Mycobacterium vaccae; OD, optical density; proliferation index is defined as the ratio of counts per minute in the well stimulated with MV sonicate over the counts per minute in the medium control well; TB, tuberculosis